These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36349892)

  • 1. Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma.
    Tringale KR; Wolden SL; Casey DL; Kushner BH; Luo L; Pandit-Taskar N; Souweidane M; Cheung NV; Modak S; Basu EM; Kramer K
    Pediatr Blood Cancer; 2023 Feb; 70(2):e30075. PubMed ID: 36349892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastoma.
    Luo LY; Kramer K; Cheung NV; Kushner BH; Modak S; Basu EM; Roberts SS; Wolden SL
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28364. PubMed ID: 32608559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma.
    Kramer K; Kushner BH; Modak S; Pandit-Taskar N; Smith-Jones P; Zanzonico P; Humm JL; Xu H; Wolden SL; Souweidane MM; Larson SM; Cheung NK
    J Neurooncol; 2010 May; 97(3):409-18. PubMed ID: 19890606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low incidence of radionecrosis in children treated with conventional radiation therapy and intrathecal radioimmunotherapy.
    Kramer K; Pandit-Taskar N; Zanzonico P; Wolden SL; Humm JL; DeSelm C; Souweidane MM; Lewis JS; Cheung NK
    J Neurooncol; 2015 Jun; 123(2):245-9. PubMed ID: 25944385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole neuraxis irradiation to address central nervous system relapse in high-risk neuroblastoma.
    Croog VJ; Kramer K; Cheung NK; Kushner BH; Modak S; Souweidane MM; Wolden SL
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):849-54. PubMed ID: 20207502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodality treatment for recurrent neuroblastoma in the central nervous system.
    Desai AV; Elmuti L; Cahaney C; De Guzman RM; Streby KA; Cohn SL
    Pediatr Blood Cancer; 2023 Apr; 70(4):e30227. PubMed ID: 36720647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma.
    Tringale KR; Wolden SL; Karajannis M; Haque S; Pasquini L; Yildirim O; Rosenblum M; Benhamida JK; Cheung NK; Souweidane M; Basu EM; Pandit-Taskar N; Zanzonico PB; Humm JL; Kramer K
    J Neurooncol; 2023 Mar; 162(1):69-78. PubMed ID: 36853490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience.
    Berlanga P; Pasqualini C; Pötschger U; Sangüesa C; Castellani MR; Cañete A; Luksch R; Elliot M; Schreier G; Kropf M; Morgenstern D; Papadakis V; Ash S; Ruud E; Brock P; Wieczorek A; Kogner P; Trahair T; Ambros P; Boterberg T; Castel V; Valteau-Couanet D; Ladenstein R
    Eur J Cancer; 2021 Feb; 144():1-8. PubMed ID: 33316634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective neurocognitive evaluation of children treated with additional chemotherapy and craniospinal irradiation following isolated central nervous system relapse in acute lymphoblastic leukemia.
    Kumar P; Mulhern RK; Regine WF; Rivera GK; Kun LE
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):561-6. PubMed ID: 7852120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Craniospinal irradiation for CNS leukemia: rates of response and durability of CNS control.
    Ebadi M; Morse M; Gooley T; Ermoian R; Halasz LM; Lo SS; Yang JT; Blau MH; Percival ME; Cassaday RD; Graber J; Taylor LP; Venur V; Tseng YD
    J Neurooncol; 2024 Jan; 166(2):351-357. PubMed ID: 38244173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase 1 study of intraventricular
    Kramer K; Pandit-Taskar N; Kushner BH; Zanzonico P; Humm JL; Tomlinson U; Donzelli M; Wolden SL; Haque S; Dunkel I; Souweidane MM; Greenfield JP; Tickoo S; Lewis JS; Lyashchenko SK; Carrasquillo JA; Chu B; Horan C; Larson SM; Cheung NV; Modak S
    J Hematol Oncol; 2022 Nov; 15(1):165. PubMed ID: 36371226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypofractionated moderate dose radiation, intrathecal chemotherapy, and repetitive reinduction/reconsolidation systemic therapy for central nervous system relapse of acute lymphoblastic leukemia in children.
    Belasco JB; Goldwein JW; Simms S; Griffin G; D'Angio G; Lange B
    Med Pediatr Oncol; 2000 Feb; 34(2):125-31. PubMed ID: 10657874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia.
    Kumar P; Kun LE; Hustu HO; Mulhern RK; Hancock ML; Coffey D; Rivera GK
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):477-83. PubMed ID: 7852109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and neurocognitive outcomes after cranial or craniospinal irradiation plus total-body irradiation before stem cell transplantation in pediatric leukemia patients with central nervous system involvement.
    Hiniker SM; Agarwal R; Modlin LA; Gray CC; Harris JP; Million L; Kiamanesh EF; Donaldson SS
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):67-74. PubMed ID: 24725690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease.
    Calaminus G; Kortmann R; Worch J; Nicholson JC; Alapetite C; Garrè ML; Patte C; Ricardi U; Saran F; Frappaz D
    Neuro Oncol; 2013 Jun; 15(6):788-96. PubMed ID: 23460321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety profile of long-term intraventricular access devices in pediatric patients receiving radioimmunotherapy for central nervous system malignancies.
    Kramer K; Smith M; Souweidane MM
    Pediatr Blood Cancer; 2014 Sep; 61(9):1590-2. PubMed ID: 24777835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival after chemotherapy and stem cell transplant followed by delayed craniospinal irradiation is comparable to upfront craniospinal irradiation in pediatric embryonal brain tumor patients.
    Raleigh DR; Tomlin B; Buono BD; Roddy E; Sear K; Byer L; Felton E; Banerjee A; Torkildson J; Samuel D; Horn B; Braunstein SE; Haas-Kogan DA; Mueller S
    J Neurooncol; 2017 Jan; 131(2):359-368. PubMed ID: 27778212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postponed is not canceled: role of craniospinal radiation therapy in the management of recurrent infant medulloblastoma--an experience from the HIT-REZ 1997 & 2005 studies.
    Müller K; Mynarek M; Zwiener I; Siegler N; Zimmermann M; Christiansen H; Budach W; Henke G; Warmuth-Metz M; Pietsch T; von Hoff K; von Bueren A; Bode U; Rutkowski S; Kortmann RD; Fleischhack G; Tippelt S
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1019-24. PubMed ID: 24661654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemia.
    Sanders KE; Ha CS; Cortes-Franco JE; Koller CA; Kantarjian HM; Cox JD
    Cancer; 2004 May; 100(10):2176-80. PubMed ID: 15139061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Craniospinal irradiation as part of re-irradiation for children with recurrent intracranial ependymoma.
    Tsang DS; Murray L; Ramaswamy V; Zapotocky M; Tabori U; Bartels U; Huang A; Dirks PB; Taylor MD; Hawkins C; Bouffet E; Laperriere N
    Neuro Oncol; 2019 Mar; 21(4):547-557. PubMed ID: 30452715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.